Cargando…

Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?

Thromboembolic events contribute to morbidity and mortality in coronavirus disease 2019 (COVID-19). As a result, thromboprophylaxis using low-molecular-weight heparin (LMWH) is universally recommended for hospitalized patients based on multiple guidelines. However, ethnic differences with respect to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iba, Toshiaki, Connors, Jean Marie, Spyropoulos, Alex C., Wada, Hideo, Levy, Jerrold H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816059/ https://www.ncbi.nlm.nih.gov/pubmed/33471294 http://dx.doi.org/10.1007/s12185-021-03078-x

Ejemplares similares

The coagulopathy, endotheliopathy, and vasculitis of COVID-19
por: Iba, Toshiaki, et al.
Publicado: (2020)

Editorial commentary: Vascular injury in acute infections and COVID-19: everything old is new again
por: Levy, Jerrold H., et al.
Publicado: (2021)

The unique characteristics of COVID-19 coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2020)

Hospital-based use of thromboprophylaxis in patients with COVID-19
por: Spyropoulos, Alex C, et al.
Publicado: (2020)

Recent advances in the research and management of sepsis-associated DIC
por: Iba, Toshiaki, et al.
Publicado: (2021)

Heatstroke-induced coagulopathy: Biomarkers, mechanistic insights, and patient management
por: Iba, Toshiaki, et al.
Publicado: (2022)

The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2023)

Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination()()
por: Iba, Toshiaki, et al.
Publicado: (2022)

Thromboprophylaxis in critical care
por: Helms, Julie, et al.
Publicado: (2022)

The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2023)

Nevertheless, the importance of coagulation abnormalities should be emphasized in international sepsis guidelines
por: Iba, Toshiaki, et al.
Publicado: (2022)

The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia
por: Iba, Toshiaki, et al.
Publicado: (2022)

New Paradigms of Extended Thromboprophylaxis in Medically Ill Patients
por: MacDougall, Kira, et al.
Publicado: (2020)

Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular Coagulation
por: Iba, Toshiaki, et al.
Publicado: (2019)

Coagulation abnormalities and thrombosis in patients with COVID-19
por: Levi, Marcel, et al.
Publicado: (2020)

Management of oral anticoagulants prior to emergency surgery or with major bleeding: A survey of perioperative practices in North America: Communication from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis
por: Levy, Jerrold H., et al.
Publicado: (2020)

Prediction of Early Death in Patients With Sepsis-Associated Coagulation Disorder Treated With Antithrombin Supplementation
por: Iba, Toshiaki, et al.
Publicado: (2018)

Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020)

Proposal of the Definition for COVID-19-Associated Coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2021)

COVID-19 and its implications for thrombosis and anticoagulation
por: Connors, Jean M., et al.
Publicado: (2020)

Coronavirus disease 2019 in pregnancy: consider thromboembolic disorders and thromboprophylaxis
por: Di Renzo, Gian Carlo, et al.
Publicado: (2020)

Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis
por: Yamakawa, Kazuma, et al.
Publicado: (2019)

Viral-Induced Inflammatory Coagulation Disorders: Preparing for Another Epidemic
por: Iba, Toshiaki, et al.
Publicado: (2021)

Intracellular communication and immunothrombosis in sepsis
por: Iba, Toshiaki, et al.
Publicado: (2022)

Identification and Outcomes of Hospitalized Medically Ill Patients Who Are Candidates for Extended Duration Thromboprophylaxis
por: Coleman, Craig I., et al.
Publicado: (2020)

Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Iba, Toshiaki, et al.
Publicado: (2021)

Interpreting recent clinical studies for COVID-19: A continual process with more new data
por: Connors, Jean M., et al.
Publicado: (2022)

Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer
por: Connors, Jean M., et al.
Publicado: (2022)

Stroke and Thromboprophylaxis in the Era of COVID-19
por: Ma, Alice, et al.
Publicado: (2021)

Coagulation abnormalities & thromboprophylaxis in COVID-19
por: Jandial, Aditya, et al.
Publicado: (2021)

Thromboprophylaxis in COVID-19 – Rationale and considerations
por: Bristogiannis, Sotirios, et al.
Publicado: (2021)

Extended Thromboprophylaxis in Patients with COVID-19
por: Zhao, Wei, et al.
Publicado: (2021)

Thromboprophylaxis strategies for COVID-19 patients
por: Porres-Aguilar, Mateo, et al.
Publicado: (2022)

Thromboprophylaxis in Patients With Cancer and COVID-19
por: Lecumberri, Ramón, et al.
Publicado: (2022)

Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials
por: Kyriakoulis, Konstantinos G., et al.
Publicado: (2022)

COVID-19 and diabetes management: What should be considered?
por: Ceriello, Antonio, et al.
Publicado: (2020)

Should statins be considered for the management of mucormycosis in COVID-19?
por: Chatterjee, Subhankar, et al.
Publicado: (2021)

Should Asian inflammatory bowel disease patients need routine thromboprophylaxis?
por: Weng, Meng-Tzu, et al.
Publicado: (2018)

Should postoperative thromboprophylaxis be used after anterior cruciate ligament reconstruction?
por: Iniguez, Xavier Bayle, et al.
Publicado: (2021)

Pharmacological Thromboprophylaxis after Major Abdominal Surgery: Should the Duration be Individualized?
por: Papageorgopoulou, Chrysanthi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c6u0h4231vuv9i63q9t1auhou4